Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment
- PMID: 39197070
- DOI: 10.1182/blood.2024024976
Genomic analysis of adult thrombotic microangiopathies in less than 3 days: from rapid to fast genomics to treatment
Abstract
Using nanopore sequencing, we showed the feasibility and impact of rapid genomic screening for managing thrombotic microangiopathies in 18 prospective cases, achieving diagnoses in <3 days. We compared the results with standard exome sequencing, cost efficiency, and complement blockade initiation.
© 2024 American Society of Hematology. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
MeSH terms
LinkOut - more resources
Full Text Sources